9780781762632

Clinical Drug Therapy Rationales for Nursing Practice

by ; ;
  • ISBN13:

    9780781762632

  • ISBN10:

    0781762634

  • Edition: 8th
  • Format: Paperback
  • Copyright: 2006-02-02
  • Publisher: LWW
  • View Upgraded Edition
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
  • Write a Review
List Price: $79.94

Summary

This popular core nursing pharmacology textbook provides unique coverage of nursing interventions for drug therapy with related rationales. Highly praised for its organized and readable presentation, the text explains the "why" behind each nursing action and emphasizes how drugs work differently in different patients. New to the Eighth Edition are case studies integrated into each chapter with case-based questions that foster critical thinking. New Research Briefs summarize current research and its nursing implications. A new chapter covers drugs for obesity, and all nutrition products have been consolidated into one chapter. New NCLEX(R)-style questions appear at the end of each drug chapter.

Table of Contents

SECTION 1 Foundations of Drug Therapy
1(72)
Introduction to Pharmacology
3(7)
A Message to Students
3(1)
Pharmacology and Drug Therapy
3(1)
Understanding Grouping and Naming of Drugs
4(1)
Prescription and Nonprescription Drugs
4(2)
Sources of Drugs
6(1)
Drug Development and Approval
6(2)
Pharmacoeconomics
8(1)
Sources of Drug Information
8(1)
Strategies for Studying Pharmacology
8(2)
Basic Concepts and Processes
10(21)
Introduction
10(1)
Cellular Physiology
10(2)
Drug Transport Through Cell Membranes
12(1)
Pharmacokinetics
12(5)
Pharmacodynamics
17(1)
Variables That Affect Drug Actions
18(7)
Adverse Effects of Drugs
25(1)
Toxicology: Drug Overdose
26(5)
Administering Medications
31(19)
Introduction
31(1)
General Principles of Accurate Drug Administration
31(1)
Legal Responsibilities
32(1)
Medication Errors
32(1)
Medication Systems
33(1)
Medication Orders
33(1)
Drug Preparations and Dosage Forms
34(2)
Calculating Drug Dosages
36(2)
Routes of Administration
38(12)
Nursing Process in Drug Therapy
50(23)
Introduction
50(1)
Nursing Process in Drug Therapy
51(5)
Integrating Nursing Process, Critical Paths, and Drug Therapy
56(6)
General Principles of Drug Therapy
62(11)
SECTION 2 Drugs Affecting the Central Nervous System
73(190)
Physiology of the Central Nervous System
75(7)
Introduction
75(1)
Basic Unit of the Central Nervous System: The Neuron
75(1)
Neurotransmission
75(3)
Major Components of the Central Nervous System
78(2)
Drugs That Affect the Central Nervous System
80(2)
Opioid Analgesics and Opioid Antagonists
82(21)
Introduction
82(1)
General Characteristics of Opioid Analgesics
83(2)
Individual Drugs
85(7)
Principles of Therapy
92(11)
Analgesic--Antipyretic--Anti-Inflammatory and Related Drugs
103(29)
Introduction
103(1)
General Characteristics of Analgesic--Antipyretic--Anti-Inflammatory and Related Drugs
104(5)
Classifications and Individual Drugs
109(10)
Principles of Therapy
119(13)
Antianxiety and Sedative-Hypnotic Drugs
132(21)
Introduction
132(3)
General Characteristics of Benzodiazepines
135(3)
Individual Drugs
138(4)
Principles of Therapy
142(11)
Antipsychotic Drugs
153(21)
Introduction
153(1)
General Characteristics of Antipsychotic Drugs
154(1)
Individual Drugs
155(8)
Principles of Therapy
163(11)
Antidepressants and Mood Stabilizers
174(19)
Introduction
174(2)
General Characteristics of Antidepressant Drugs
176(1)
Types of Antidepressants and Individual Drugs
177(5)
Principles of Therapy
182(11)
Antiseizure Drugs
193(21)
Introduction
193(1)
General Characteristics of Antiseizure Drugs
194(1)
Individual Drugs
195(8)
Principles of Therapy
203(11)
Antiparkinson Drugs
214(13)
Introduction
214(1)
General Characteristics of Antiparkinson Drugs
214(2)
Individual Antiparkinson Drugs
216(4)
Principles of Therapy
220(7)
Skeletal Muscle Relaxants
227(8)
Introduction
227(1)
General Characteristics of Skeletal Muscle Relaxants
228(1)
Individual Drugs
228(3)
Principles of Therapy
231(4)
Substance Abuse Disorders
235(18)
Introduction
235(2)
Central Nervous System Depressants
237(5)
Central Nervous System Stimulants
242(8)
Principles of Therapy
250(3)
Central Nervous System Stimulants
253(10)
Introduction
253(1)
General Characteristics of Stimulants
254(1)
Individual Drugs
254(4)
Principles of Therapy
258(5)
SECTION 3 Drugs Affecting the Autonomic Nervous System
263(70)
Physiology of the Autonomic Nervous System
265(7)
Introduction
265(1)
Structure and Function of the Autonomic Nervous System
265(6)
Characteristics of Autonomic Drugs
271(1)
Adrenergic Drugs
272(17)
Introduction
272(1)
General Characteristics of Adrenergic Drugs
272(3)
Individual Drugs
275(4)
Principles of Therapy
279(10)
Antiadrenergic Drugs
289(18)
Introduction
289(1)
General Characteristics of Antiadrenergic Drugs
289(2)
Individual Drugs
291(7)
Principles of Therapy
298(9)
Cholinergic Drugs
307(12)
Introduction
307(1)
General Characteristics of Cholinergic Drugs
308(1)
Individual Drugs
309(3)
Principles of Therapy
312(7)
Anticholinergic Drugs
319(14)
Introduction
319(1)
General Characteristics of Anticholinergic Drugs
319(2)
Individual Drugs
321(5)
Principles of Therapy
326(7)
SECTION 4 Drugs Affecting the Endocrine System
333(132)
Physiology of the Endocrine System
335(4)
Introduction
335(1)
Endocrine System--Nervous System Interactions
336(1)
General Characteristics of Hormones
336(2)
Use of Hormonal Drugs
338(1)
Hypothalamic and Pituitary Hormones
339(13)
Introduction
339(1)
Types of Hormones
339(2)
Individual Drugs
341(6)
Principles of Therapy
347(5)
Corticosteroids
352(21)
Introduction
352(3)
General Characteristics of Exogenous Corticosteroids
355(8)
Principles of Therapy
363(10)
Thyroid and Antithyroid Drugs
373(14)
Introduction
373(1)
General Characteristics of Thyroid and Antithyroid Drugs
374(2)
Individual Drugs
376(3)
Principles of Therapy
379(8)
Hormones That Regulate Calcium and Bone Metabolism
387(17)
Introduction
387(3)
Individual Drugs
390(6)
Principles of Therapy
396(8)
Antidiabetic Drugs
404(32)
Introduction
404(3)
Hypoglycemic Drugs
407(12)
Principles of Therapy
419(17)
Estrogens, Progestins, and Hormonal Contraceptives
436(19)
Introduction
436(2)
General Characteristics of Estrogens, Progestins, and Hormonal Contraceptives
438(2)
Individual Drugs
440(7)
Principles of Therapy
447(8)
Androgens and Anabolic Steroids
455(10)
Introduction
455(2)
General Characteristics of Androgens and Anabolic Steroids Used As Drugs
457(1)
Individual Drugs
458(2)
Principles of Therapy
460(5)
SECTION 5 Drugs Used to Treat Infections
465(154)
General Characteristics of Antimicrobial Drugs
467(18)
Introduction
467(1)
Microorganisms and Infections
467(7)
Characteristics of Antimicrobial Drugs
474(2)
Principles of Therapy
476(9)
Beta-Lactam Antibacterials: Penicillins, Cephalosporins, and Other Drugs
485(19)
Introduction
485(1)
Penicillins
485(4)
Cephalosporins
489(2)
Carbapenems
491(3)
Monobactam
494(1)
Principles of Therapy
495(9)
Aminoglycosides and Fluoroquinolones
504(11)
Introduction
504(1)
Aminoglycosides
504(3)
Fluoroquinolones
507(2)
Principles of Therapy
509(6)
Tetracyclines, Sulfonamides, and Urinary Agents
515(13)
Introduction
515(7)
Principles of Therapy
522(6)
Macrolides, Ketolides, and Miscellaneous Antibacterials
528(14)
Introduction
528(1)
Macrolides and Ketolides
528(2)
Miscellaneous Antibacterial Drugs
530(3)
Principles of Therapy
533(9)
Drugs for Tuberculosis and Mycobacterium avium Complex (MAC) Disease
542(18)
Introduction
542(2)
Antitubercular Drugs
544(6)
Treatment of Active Tuberculosis
550(1)
Mycobacterium avium Complex Disease
550(2)
Principles of Therapy
552(8)
Antiviral Drugs
560(22)
Introduction
560(2)
Antiviral Drugs
562(9)
Principles of Therapy
571(11)
Antifungal Drugs
582(21)
Introduction
582(1)
Antifungal Drugs
583(12)
Principles of Therapy
595(8)
Antiparasitics
603(16)
Introduction
603(3)
Antiparasitic Drugs
606(8)
Principles of Therapy
614(5)
SECTION 6 Drugs Affecting Hematopoiesis and the Immune System
619(104)
Physiology of the Hematopoietic and Immune Systems
621(12)
Introduction
621(1)
Hematopoietic Cytokines
621(3)
Overview of Body Defense Mechanisms
624(1)
Immunity
624(2)
Immune Cells
626(3)
Immune System Cytokines
629(1)
Client-Related Factors That Influence Immune Function
629(2)
Immune Disorders
631(1)
Drugs That Alter Hematopoietic and Immune Responses
632(1)
Immunizing Agents
633(18)
Introduction
633(1)
General Characteristics of Immunizing Agents
634(1)
Individual Immunizing Agents
634(10)
Principles of Therapy
644(7)
Hematopoietic and Immunostimulant Drugs
651(14)
Introduction
651(1)
General Characteristics of Hematopoietic and Immunostimulant Drugs
651(4)
Classifications and Individual Drugs
655(3)
Principles of Therapy
658(7)
Immunosuppressants
665(26)
Introduction
665(3)
Classifications and Individual Drugs
668(8)
Principles of Therapy
676(15)
Drugs Used in Oncologic Disorders
691(32)
Introduction
691(3)
Traditional Cytotoxic Antineoplastic Drugs
694(5)
Biologic Targeted Antineoplastic Drugs
699(3)
Antineoplastic Hormone Inhibitor Drugs
702(3)
Cytoprotectant Drugs
705(4)
Principles of Therapy
709(14)
SECTION 7 Drugs Affecting the Respiratory System
723(48)
Physiology of the Respiratory System
725(4)
Overview of the Respiratory System
725(2)
Disorders of the Respiratory System
727(1)
Drug Therapy
727(2)
Drugs for Asthma and Other Bronchoconstrictive Disorders
729(18)
Introduction
729(3)
Bronchodilators
732(3)
Anti-Inflammatory Agents
735(4)
Principles of Therapy
739(8)
Antihistamines and Allergic Disorders
747(13)
Introduction
747(3)
General Characteristics of Antihistamines
750(3)
Classifications and Individual Drugs
753(2)
Principles of Therapy
755(5)
Nasal Decongestants, Antitussives, and Cold Remedies
760(11)
Introduction
760(1)
General Characteristics of Drugs Used in/for Respiratory Disorders
761(1)
Individual Drugs
762(4)
Principles of Therapy
766(5)
SECTION 8 Drugs Affecting the Cardiovascular System
771(140)
Physiology of the Cardiovascular System
773(4)
Introduction
773(1)
Heart
773(1)
Blood Vessels
774(1)
Blood
775(1)
Cardiovascular Disorders
776(1)
Drug Therapy Used for Cardiovascular Disorders
776(1)
Drug Therapy for Heart Failure
777(17)
Introduction
777(1)
Inotropes
778(5)
Human B-Type Natriuretic Peptide (Nesiritide)
783(1)
Endothelin Receptor Antagonists (Bosentan)
784(1)
Principles of Therapy
785(9)
Antidysrhythmic Drugs
794(20)
Introduction
794(2)
General Characteristics of Antidysrhythmic Drugs
796(1)
Classifications and Individual Drugs
796(11)
Principles of Therapy
807(7)
Antianginal Drugs
814(15)
Introduction
814(3)
Antianginal Drugs: Classifications and Individual Drugs
817(6)
Principles of Therapy
823(6)
Drugs Used in Hypotension and Shock
829(9)
Introduction
829(1)
General Characteristics of Antishock Drugs
830(1)
Individual Drugs
830(3)
Principles of Therapy
833(5)
Antihypertensive Drugs
838(23)
Introduction
838(4)
Antihypertensives: Classifications and Individual Drugs
842(9)
Principles of Therapy
851(10)
Diuretics
861(15)
Introduction
861(2)
General Characteristics of Diuretic Drugs
863(2)
Types of Diuretics and Individual Drugs
865(3)
Principles of Therapy
868(8)
Drugs That Affect Blood Coagulation
876(21)
Introduction
876(3)
Drugs Used in Thrombotic and Thromboembolic Disorders: Classifications and Individual Drugs
879(9)
Principles of Therapy
888(9)
Drugs for Dyslipidemia
897(14)
Introduction
897(3)
General Characteristics of Drugs Used for Management of Dyslipidemia
900(1)
Dyslipidemic Drugs: Classifications and Individual Drugs
901(4)
Principles of Therapy
905(6)
SECTION 9 Drugs Affecting the Digestive System
911(110)
Physiology of the Digestive System
913(4)
Introduction
913(1)
Structures of the Digestive System
913(2)
Secretions of the Digestive System
915(1)
Effects of Drugs on the Digestive System
916(1)
Nutritional Support Products, Vitamins, and Mineral-Electrolytes
917(35)
Introduction
917(1)
Nutritional Deficiency States
917(1)
Nutritional Products
918(7)
Agents Used in Mineral-Electrolyte Imbalances
925(10)
Principles of Therapy
935(17)
Drugs to Aid Weight Management
952(18)
Introduction
952(5)
General Characteristics of Drugs for Obesity
957(1)
Individual Drugs
957(3)
Principles of Therapy
960(10)
Drugs Used for Peptic Ulcer and Acid Reflux Disorders
970(17)
Introduction
970(2)
Classifications and Individual Drugs
972(8)
Principles of Therapy
980(7)
Laxatives and Cathartics
987(10)
Introduction
987(1)
General Characteristics of Laxatives and Cathartics
988(1)
Classifications and Individual Drugs
988(4)
Principles of Therapy
992(5)
Antidiarrheals
997(13)
Introduction
997(1)
Characteristics, Classifications, and Individual Antidiarrheal Drugs
998(6)
Principles of Therapy
1004(6)
Antiemetics
1010(11)
Introduction
1010(1)
General Characteristics of Antiemetic Drugs
1011(1)
Classifications and Individual Drugs
1011(4)
Principles of Therapy
1015(6)
SECTION 10 Drugs Used in Special Conditions
1021(58)
Drugs Used in Ophthalmic Conditions
1023(16)
Introduction
1023(1)
Ophthalmic Drug Therapy
1024(8)
Principles of Therapy
1032(7)
Drugs Used in Dermatologic Conditions
1039(18)
Introduction
1039(3)
Dermatologic Drug Therapy
1042(7)
Principles of Therapy
1049(8)
Drug Use During Pregnancy and Lactation
1057(22)
Introduction
1057(1)
Pregnancy
1057(2)
Fetal Therapeutics
1059(1)
Maternal Therapeutics
1059(10)
Drugs That Alter Uterine Motility
1069(2)
Drugs Used During Labor and Delivery at Term
1071(1)
Neonatal Therapeutics
1072(1)
Principles of Therapy
1073(6)
Appendix A Recently Approved and Miscellaneous Drugs 1079(3)
Appendix B The International System of Units 1082(1)
Appendix C Serum Drug Concentrations 1083(1)
Appendix D Canadian Drug Laws and Standards 1084(3)
Appendix E Canadian Drug Names 1087(8)
Appendix F Anesthetics, Adjunctive Drugs, and Nursing Considerations 1095(6)
Index 1101

Rewards Program

Write a Review